Loading clinical trials...
Loading clinical trials...
Traditionally, surgery has been the standard recommendation for treating papillary thyroid cancer. The risk of surgery including permanent hoarseness, permanent hypocalcemia, a mid-cervical scar, and ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Johns Hopkins University
Collaborators
NCT06316895 · Papillary Thyroid Cancer
NCT07140757 · Low Risk, Papillary Thyroid Cancer, and more
NCT05024929 · Papillary Thyroid Cancer, Pediatric Cancer, and more
NCT05766098 · Papillary Thyroid Cancer
NCT04948437 · Thyroid Cancer, Papillary Thyroid Cancer, and more
Johns Hopkins Hospital
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions